Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1… is a federal award for National Institutes Of Health - Cc held by Roche Diagnostics Corp. Estimated value $3.2M ($2.1M obligated). Current period of performance ends Apr 30, 2024 (potential Apr 30, 2025). Last award drew 1 bidder. Place of performance: INDIANAPOLIS IN.
To administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 u.s.c. section 1552 (a), in preparation for september 30, 2026, closing of the period of availability of these fiscal year funds. Latest action is a modification.
Recompete timing
PublicCurrent PoP ended Apr 30, 2024 (905 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on 75N90020F00065? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordRoche Diagnostics Corp — $245.9M obligated across 1,391 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N90020F00065?
75N90020F00065 (Administratively de-obligate unexpended and) is a National Institutes Of Health - Cc award with a potential value of $3.2M, currently held by Roche Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N90020F00065?
National Institutes Of Health - Cc awarded 75N90020F00065 to Roche Diagnostics Corp (potential $3.2M).
Who is the incumbent on 75N90020F00065?
Roche Diagnostics Corp is the incumbent with $245.9M across 1391 related awards in SCOUT’s public footprint. The current period of performance ends Apr 30, 2024.
When does Roche Diagnostics Corp’s 75N90020F00065 come up for recompete?
SCOUT tracks a period-of-performance end of Apr 30, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75N90020F00065? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.